Literature DB >> 9283535

Optimizing timing of surgical correction in patients with severe aortic regurgitation: role of symptoms.

E Klodas1, M Enriquez-Sarano, A J Tajik, C J Mullany, K R Bailey, J B Seward.   

Abstract

OBJECTIVES: We sought to determine the independent effect of preoperative symptoms on survival after surgical correction of aortic regurgitation (AR).
BACKGROUND: Aortic valve replacement for severe AR is recommended after New York Heart Association functional class III or IV symptoms develop. However, whether severe preoperative symptoms have a negative influence on postoperative survival remains controversial.
METHODS: Preoperative characteristics and postoperative survival in 161 patients with functional class I or II symptoms (group 1) were compared with those in 128 patients with class III or IV symptoms (group 2) undergoing surgical repair of severe isolated AR between 1980 and 1989.
RESULTS: Compared with group 1, group 2 patients were older (p < 0.0001), were more often female (p = 0.001) and more often had a history of hypertension (p = 0.001), diabetes mellitus (p = 0.029) or myocardial infarction (p = 0.005) and were more likely to require coronary artery bypass graft surgery (p < 0.0001). The operative mortality rate was higher in group 2 (7.8%) than in group 1 (1.2%, p = 0.005), and the 10-year postoperative survival rate was worse (45% +/- 5% [group 2] vs. 78% +/- 4% [group 1], p < 0.0001). Compared with age- and gender-matched control subjects, long-term postoperative survival was similar to that expected in group 1 (p = 0.14) but significantly worse in group 2 (p < 0.0001). On multivariate analysis, functional class III or IV symptoms were significant independent predictors of operative mortality (adjusted odds ratio 5.5, p = 0.036) and worse long-term postoperative survival (adjusted hazard ratio 1.81, p = 0.0091).
CONCLUSIONS: In the setting of severe AR, preoperative functional class III or IV symptoms are independent risk factors for excess immediate and long-term postoperative mortality. The presence of class II symptoms should be a strong incentive to consider immediate surgical correction of severe AR.

Entities:  

Mesh:

Year:  1997        PMID: 9283535     DOI: 10.1016/s0735-1097(97)00205-2

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  27 in total

Review 1.  Aortic regurgitation.

Authors:  Gerald Maurer
Journal:  Heart       Date:  2006-07       Impact factor: 5.994

2.  Predictors of left ventricular performance after valve replacement in children and adolescents with chronic aortic regurgitation.

Authors:  R I Tafreshi; A Shahmohammadi; P N Davari
Journal:  Pediatr Cardiol       Date:  2005 Jul-Aug       Impact factor: 1.655

Review 3.  Outcomes following transcatheter aortic valve replacement in patients with native aortic valve regurgitation.

Authors:  Tamunoinemi Bob-Manuel; Siri Kadire; Mark R Heckle; Jiajing Wang; Uzoma N Ibebuogu
Journal:  Ann Transl Med       Date:  2018-01

Review 4.  Assessment and management of aortic valve disease in patients with left ventricular dysfunction.

Authors:  Mackram F Eleid; Sunil Mankad; Paul Sorajja
Journal:  Heart Fail Rev       Date:  2013-01       Impact factor: 4.214

5.  Valvular regurgitation and stenosis: when is surgery required?

Authors:  R Goel; P P Sengupta; F Mookadam; H P Chaliki; B K Khandheria; A J Tajik
Journal:  Heart Asia       Date:  2009-01-01

Review 6.  Current Management of Patients with Severe Aortic Regurgitation.

Authors:  Charles Nadeau-Routhier; Ons Marsit; Jonathan Beaudoin
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-02

Review 7.  Aortic Regurgitation.

Authors:  Nir Flint; Nina C Wunderlich; Hezzy Shmueli; Sagit Ben-Zekry; Robert J Siegel; Roy Beigel
Journal:  Curr Cardiol Rep       Date:  2019-06-03       Impact factor: 2.931

8.  Assessment of left ventricular long axis contraction can detect early myocardial dysfunction in asymptomatic patients with severe aortic regurgitation.

Authors:  D Vinereanu; A A Ionescu; A G Fraser
Journal:  Heart       Date:  2001-01       Impact factor: 5.994

Review 9.  What is new in the 2006 ACC/AHA guidelines on valvular heart disease?

Authors:  Blase A Carabello
Journal:  Curr Cardiol Rep       Date:  2008-03       Impact factor: 2.931

10.  Inference in a survival cure model with mismeasured covariates using a simulation-extrapolation approach.

Authors:  Aurelie Bertrand; Catherine Legrand; Raymond J Carroll; Christophe De Meester; Ingrid Van Keilegom
Journal:  Polit Anal       Date:  2017-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.